eDiagnosis announced that, based on preliminary calculations, the company's total profit for the year 2025 is expected to be a loss of 50 million to 75 million yuan, with a net profit expected to be a loss of 15 million to 25 million yuan. The net profit excluding non-recurring items is expected to be a loss of 100 million to 140 million yuan, with expected operating revenue of 250 million to 310 million yuan, and operating revenue after deductions of 237 million to 297 million yuan. According to relevant regulations, the company's stock trading may be subject to delisting risk warnings after the disclosure of the 2025 annual report. If relevant circumstances are triggered, the company's stock will be suspended for one trading day, and after resumption, a delisting warning will be implemented